Daratumumab 1800 milligram (mg) will be administered as a fixed dose by subcutaneous (SC) injection.
Janssen Research & Development, LLC Clinical Trial
Janssen Research & Development, LLC
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.